Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
345.6 DKK | +5.37% | +9.78% | -10.93% |
Apr. 12 | Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024 | CI |
Apr. 12 | ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24 | CI |
Sales 2024 * | 404M 58.63M | Sales 2025 * | 461M 66.81M | Capitalization | 6.01B 872M |
---|---|---|---|---|---|
Net income 2024 * | 127M 18.42M | Net income 2025 * | 153M 22.19M | EV / Sales 2024 * | 14 x |
Net cash position 2024 * | 338M 49.01M | Net cash position 2025 * | 396M 57.48M | EV / Sales 2025 * | 12.2 x |
P/E ratio 2024 * |
47.2
x | P/E ratio 2025 * |
39.4
x | Employees | 171 |
Yield 2024 * |
1.88% | Yield 2025 * |
2.31% | Free-Float | 100% |
Latest transcript on ChemoMetec A/S
1 day | +5.37% | ||
1 week | +15.12% | ||
Current month | +15.59% | ||
1 month | +17.15% | ||
3 months | -21.17% | ||
6 months | +6.67% | ||
Current year | -10.93% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 65 | 96-12-31 | |
Director of Finance/CFO | - | 22-10-31 | |
Søren Kjærulff
CTO | Chief Tech/Sci/R&D Officer | - | 07-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Reich
BRD | Director/Board Member | 62 | 14-09-30 |
Founder | 65 | 96-12-31 | |
Kristine Færch
BRD | Director/Board Member | 48 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 345.6 | +5.37% | 169,916 |
24-05-13 | 328 | +4.86% | 175,621 |
24-05-08 | 312.8 | -0.64% | 83,650 |
24-05-07 | 314.8 | +4.86% | 70,583 |
Delayed Quote Nasdaq Copenhagen, May 14, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.93% | 826M | |
+73.70% | 12.4B | |
-17.02% | 7.94B | |
-1.68% | 6.17B | |
+16.74% | 5.55B | |
-3.21% | 5.35B | |
+46.20% | 5.03B | |
-17.73% | 4.07B | |
-29.91% | 2.65B | |
-0.74% | 1.99B |
- Stock Market
- Equities
- CHEMM Stock